In value terms, private equity deal activity in Germany decreased by 38% in Q2 2023 compared with the previous quarter’s total of $435m. Related deal volume increased by 50% in Q2 2023 versus the previous quarter and was 200% higher than in Q2 2022.
The top-ranked financial advisors supporting these private equity deals in Germany in Q2 2023 were Deloitte Touche Tohmatsu; Flick Gocke Schaumburg; Houlihan Lokey with 1, 1, 1 deals respectively.
The top-ranked legal advisorss supporting these private equity deals in Germany Q2 2023 were Baker & McKenzie; Gowling WLG International; Hengeler Mueller Partnerschaft von Rechtsanwalten mbB with 2, 1, 1 deals respectively.
For further understanding of GlobalData’s Pharma Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Buyouts and Direct Investments done by Private Equity firms.